SCHEMBL4654347

SCHEMBL4654347

C/C=C/CCC(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4654350 1.00
SCHEMBL29257651 0.84 ALDH1A1 (0.43)
SCHEMBL6400880 0.82 ACLY (0.42)
SCHEMBL6400884 0.82 ACLY (0.42)
SCHEMBL10588994 0.80 ACLY (0.45)
SCHEMBL5272710 0.80 ACLY (0.45)
SCHEMBL5272707 0.80 ACLY (0.45)
SCHEMBL1023227 0.78
SCHEMBL30891556 0.77
SCHEMBL2282242 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11485867-B2 Ink composition SEIKO EPSON CORPORATION 2022-11-01 US disclosed
US-20200283650-A1 INK COMPOSITION SEIKO EPSON CORPORATION (JP) 2020-09-10 US disclosed
US-9029293-B2 Tobacco axillary bud inhibitor and tobacco axillary bud-inhibiting method SDS BIOTECH K.K. (JP) 2015-05-12 US disclosed
US-8865624-B2 Inhibitor for tobacco axillary bud growth and method for inhibiting tobacco axillary bud growth SDS BIOTECH K.K. (JP) 2014-10-21 US disclosed
US-20140121112-A1 TOBACCO AXILLARY BUD INHIBITOR AND TOBACCO AXILLARY BUD-INHIBITING METHOD SDS BIOTECH K.K. (JP) 2014-05-01 US disclosed
US-20130157857-A1 INHIBITOR FOR TOBACCO AXILLARY BUD GROWTH AND METHOD FOR INHIBITING TOBACCO AXILLARY BUD GROWTH SDS BIOTECH K.K. (JP) 2013-06-20 US disclosed
EP-1855705-A4 ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF VICURON PHARM INC (US) 2008-11-12 EP disclosed
EP-1855705-A1 ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF Vicuron Pharmaceuticals, Inc. (US) 2007-11-21 EP disclosed
WO-2006075988-A1 ANTIBIOTIC 107891, ITS FACTORS A1 AND A2, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF VICURON PHARMACEUTICALS INC. (US) 2006-07-20 WO disclosed